DePuy Hip Implant Lawsuit 2026: The $2.5B ASR Settlement, the $1B Pinnacle Verdict & Who Can Still File

Direct answer: DePuy hip implant lawsuits cover two metal-on-metal devices: the ASR, recalled worldwide in August 2010 after high failure rates, and the Pinnacle, which Texas juries found defective in 2016. Johnson & Johnson paid at least $2.5 billion settling roughly 8,000 ASR claims, while Pinnacle juries awarded $502 million and $1.04 billion. Under state deadlines, some claims remain viable in 2026.

Key facts:

  • August 2010: DePuy recalled the ASR hip system worldwide after registry data showed high revision rates; the company said about 93,000 ASR implants had been used worldwide.
  • November 2013: J&J agreed to pay at least $2.5 billion to settle roughly 8,000 ASR lawsuits; a further settlement reported at about $1 billion followed in 2015.
  • March 2016: a Dallas jury awarded $502 million to five patients over the Pinnacle hips — $142 million in compensatory damages and $360 million in punitive damages.
  • December 2016: a second Dallas jury awarded $1.04 billion to six patients, with only about $30 million of it compensatory — one of the largest U.S. verdicts that year.
  • J&J discontinued the Pinnacle metal-on-metal hips in 2013, the same year it stopped defending their design in the face of nearly 9,000 pending federal lawsuits.

What Went Wrong With DePuy's Metal-on-Metal Hips

A metal-on-metal hip is an artificial hip in which both the ball and the socket are made of metal alloys, typically cobalt and chromium. The idea was that metal components would be more durable and suit younger, active patients better than metal-on-plastic designs. In practice, the surfaces grind against each other with every step, shedding microscopic metal debris into the surrounding tissue and sometimes the bloodstream.

A revision surgery is a second operation to remove or replace a failed implant. It is far more difficult than the original hip replacement: bone may have been lost, scar tissue complicates access, and recovery is longer. Registry data in Australia and England showed the DePuy ASR failing — meaning patients needed revision — at rates that shocked surgeons: roughly 12 to 13 percent of ASR resurfacing implants failed within five years, multiples of what doctors expected from a hip device.

The ASR Recall of August 2010

In August 2010, DePuy Orthopaedics, J&J's medical-device arm, announced a worldwide recall of the ASR hip system, including the ASR XL Acetabular System and the ASR Hip Resurfacing System. The trigger was data from national joint registries showing revision rates far above the norm. DePuy itself said about 93,000 ASR systems had been implanted worldwide — roughly 37,000 of them in the United States.

The recall did not fix the implants already in people's bodies. Patients were told to see their surgeons annually for at least five years, to get blood tests for metal ion levels, and to report new pain, swelling, or changes in walking. Many discovered that their implants were already shedding dangerous levels of metal debris.

The $2.5 Billion ASR Settlement — and What It Covered

In November 2013, Johnson & Johnson agreed to pay at least $2.5 billion to settle roughly 8,000 lawsuits over the ASR hips, making it one of the largest medical-device settlements in U.S. history at the time. Claimants who had undergone revision surgery were eligible for a base award; those with exceptional injuries could seek more through a separate process. A further settlement reported at about $1 billion followed in 2015, covering additional revision cases.

These were global resolutions of the ASR claims — but they did not touch the second DePuy device, the Pinnacle, whose litigation was only getting started. That distinction matters: if you had an ASR, your claim likely ran through the settlement program; if you had a Pinnacle, your claim belonged to an entirely different — and in some ways more dramatic — chapter.

The Pinnacle Trials: $502 Million, Then $1.04 Billion

The Pinnacle Hip Replacement System reached the market in 2000 and was discontinued in 2013 after the FDA toughened artificial-hip regulations. Unlike the ASR, the Pinnacle was never recalled — yet nearly 9,000 federal lawsuits accused J&J of mishandling the metal-on-metal hips, consolidated before a federal judge in Dallas.

The bellwether trials produced staggering verdicts. In March 2016, a Dallas jury awarded $502 million to five patients — $142 million in compensatory damages and $360 million in punitive damages — after concluding the Pinnacle hips were defective and J&J knew of the flaws but failed to warn patients and doctors. In December 2016, another Dallas jury went further: $1.04 billion to six patients, of which only about $30 million was compensatory and the rest punitive — the third-largest U.S. jury award of 2016, according to Bloomberg's tally.

Signs Your Hip Implant May Be Failing

Two medical terms dominate this litigation, and both are worth defining in plain language. Metallosis is tissue damage and inflammation caused by metal debris accumulating around an implant; it can destroy muscle and bone and push metal ions into the bloodstream. ALVAL (aseptic lymphocyte-dominated vasculitis-associated lesion) is an immune reaction to that debris — essentially the body's tissue becoming inflamed around the metal particles.

Patients described a consistent pattern: groin or hip pain that returned months or years after a successful replacement, swelling or a limp, a popping or grinding sensation, and in some cases symptoms far from the hip — fatigue, skin rashes, or neurological complaints that doctors linked to elevated cobalt and chromium in the blood. Blood tests showing metal ion levels several times the expected range are a red flag surgeons take seriously.

Who Can Still File a DePuy Lawsuit in 2026

The statute of limitations — the legal deadline for filing a lawsuit — is set by each state and typically runs from when you knew, or should have known, your implant was defective. That discovery-based rule is why some claims remain alive years after the recall: many patients only connected their pain to the implant after blood tests or a revision consultation.

Compensation varies widely by case, depending on revision surgery, lost income, medical costs, and the strength of causation evidence. Most settlements are confidential, so public averages are unreliable — the headline verdicts above reflect specific juries and specific plaintiffs, not a standard payout. The practical step is unchanged: gather your implant records and speak with a mass-tort attorney who can check your state's deadline before it passes.

How Filing Works: MDLs, Bellwether Trials, and Timelines

DePuy cases were consolidated in federal multidistrict litigation, where bellwether trials — a small set of representative cases tried first — signal how the larger pool might fare. The Pinnacle bellwethers are why the litigation produced billion-dollar headlines; both sides watched them to calibrate settlement posture.

Mass-tort lawyers typically work on a contingency fee: you pay nothing upfront, and the lawyer takes an agreed percentage of any recovery, plus case costs. You will be asked for your surgical records, the implant's product stickers or operative report, blood-test results, and a timeline of symptoms. Cases move slowly — device litigations routinely take years — but the settlement infrastructure built for ASR and Pinnacle means the mechanics are well established.

For more explainers on complex consumer cases, see the Problem Solved channel. If your story involves a different device or drug, our related coverage may help: the pressure-cooker explosion litigation, the Xeljanz lawsuit, and what happens when pre-settlement funding is denied.

Who Benefits From This — and Who Does Not

A DePuy file turns on which device you received and what your records show, because the ASR and Pinnacle stories ended very differently: the ASR was recalled in August 2010 and settled for at least $2.5 billion, while the Pinnacle was never recalled but produced the $502 million and $1.04 billion jury verdicts.

Who benefits:

  • ASR recipients who had revision surgery or still carry an unrevised implant with new symptoms: The ASR settlement program closed years ago, but individual claims involving unrevised implants or late-discovered injuries can still be filed, subject to state deadlines.
  • Pinnacle recipients with metallosis symptoms: Returning groin or hip pain, swelling, limping, or grinding sensations, sometimes with fatigue or rashes linked to elevated cobalt and chromium, match the pattern juries heard in the bellwether trials.
  • People whose operative report names the device: The operative report or the implant product stickers in your surgical records identify whether you had an ASR or a Pinnacle, which decides which litigation path applies.

Who benefits little or not at all:

  • People with a non-metal-on-metal hip implant: These cases concern metal-on-metal devices specifically; other implant materials raise different questions.
  • People who assume the ASR settlement program is still open: That program closed to new claimants years ago; what may remain are individual claims for unrevised implants or late-discovered injuries, which an attorney must check against your state's rules.
  • People with no symptoms and no device records yet: The first step is obtaining the operative report from your surgeon or hospital, not filing; without knowing the device, no claim can be evaluated.

Related reading: Fosamax Lawsuit 2026: Merck's $27.7M Jaw Settlement, the Revived Femur-Fracture Cases & Who Can File.

Frequently Asked Questions

Is the DePuy hip lawsuit still open in 2026?

The ASR settlement program closed to new claimants years ago, but individual claims involving unrevised implants, late-discovered injuries, or state tolling rules can still be filed — an attorney can check your state's deadline in one consultation.

What were the symptoms of a failing DePuy hip?

Returning groin or hip pain, swelling, limping, grinding sensations, and sometimes fatigue or rashes linked to elevated cobalt and chromium levels in blood tests.

How much did DePuy pay in settlements and verdicts?

Documented figures: at least $2.5 billion to settle roughly 8,000 ASR cases in 2013, a further ~$1 billion settlement in 2015, and Pinnacle jury verdicts of $502 million (March 2016) and $1.04 billion (December 2016) — those verdicts reflect specific plaintiffs, not standard payouts.

How do I know which DePuy device I have?

Your operative report or the implant product stickers in your surgical records name the device. Your surgeon's office or the hospital's medical-records department can provide them on request.

Who benefits from a DePuy claim — and who does not?

ASR recipients with revision surgery or late symptoms from an unrevised implant, and Pinnacle recipients with metallosis symptoms such as returning hip pain, swelling, or grinding, benefit most when their operative report names the device. Non-metal-on-metal implants fall outside these cases, the ASR settlement program itself closed years ago, and without device records a claim cannot yet be evaluated.

How do I start a DePuy claim?

Get your operative report or implant product stickers from your surgeon or hospital to confirm whether you had an ASR or a Pinnacle. Collect records of revision surgery, blood tests for metal ion levels, and any new pain or swelling, then have an attorney check your state's deadline, since it usually runs from when you knew or should have known the implant was defective. Most firms work on a contingency fee.

This article is general information, not legal or medical advice. If you believe a medical device injured you, consult a qualified attorney in your state and a physician about your symptoms.

Watch on YouTube

Problem Solved on YouTube